表紙
市場調査レポート

外傷性脊髄損傷:世界の治験レビュー

Traumatic Spinal Cord Injury Global Clinical Trials Review, H2, 2014

発行 GlobalData 商品コード 310343
出版日 ページ情報 英文 58 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.50円で換算しております。
Back to Top
外傷性脊髄損傷:世界の治験レビュー Traumatic Spinal Cord Injury Global Clinical Trials Review, H2, 2014
出版日: 2014年08月12日 ページ情報: 英文 58 Pages
概要

当レポートでは、外傷性脊髄損傷に関する臨床研究の最新動向について分析し、疾患治療法の概要や、治験における主要国、G7諸国およびE7(新興7カ国)における治験数および被験者採用の状況、フェーズ(相)段階別の進行状況、有望なスポンサー、各企業研究機関での研究の進行状況、有望な薬剤の比較といった情報をまとめてお届けします。

目次

イントロダクション

  • 外傷性脊髄損傷
  • 当レポートの概要

各地域における治験状況

  • 各国の治験件数と平均被験者数
    • アジア太平洋の主要国における治験件数
    • 欧州の主要国における治験件数
    • 北米の主要国における治験件数
    • 中東およびアフリカにおける治験件数

G7諸国での治験件数:中枢神経系の治験件数に対する外傷性脊髄損傷の治験件数比率

G7諸国での治験件数:フェーズ(相)別

G7諸国での治験件数:進捗状況別

E7諸国(新興7ヶ国)での治験件数:中枢神経系の治験件数に対する外傷性脊髄損傷の治験件数比率

E7諸国(新興7ヶ国)での治験件数:フェーズ(相)別

フェーズ(相)別の治験件数

  • 進行中の治験:フェーズ(相)別

進捗状況別の治験件数

エンドポイント達成状況別の治験件数

未達成の治験件数

一定期間に採用された被験者

スポンサーの種類別治験件数

有望なスポンサー

有望な薬剤

治験のプロファイル

  • 代表的な企業の治験概要
    • Stem Cell Sciences UK Ltd
    • NuVasive, Inc.
    • AOSpine International
    • Acorda Therapeutics, Inc.
  • 代表的な研究機関・病院の治験の概要
    • Simon Fraser University
    • Tehran University of Medical Sciences
    • Shanghai Changzheng Hospital
    • Christian Medical College
    • Indian Council of Medical Research
    • Rennes University Hospital
    • Yonsei University
    • Capital District Health Authority, Canada
    • Hadassah Medical Organization
    • University of Miami

5つの代表的な治験のプロファイル

付録

図表一覧

目次

GlobalData's clinical trial report, "Traumatic Spinal Cord Injury Global Clinical Trials Review, H2, 2014" provides data on the Traumatic Spinal Cord Injury clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Traumatic Spinal Cord Injury. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Traumatic Spinal Cord Injury. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Traumatic Spinal Cord Injury
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
  • Clinical Trials by G7 Countries: Proportion of Traumatic Spinal Cord Injury to Central Nervous System Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Traumatic Spinal Cord Injury to Central Nervous System Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Unaccomplished Trials of Traumatic Spinal Cord Injury
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Traumatic Spinal Cord Injury Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Stem Cell Sciences UK Ltd
      • Clinical Trial Overview of Stem Cell Sciences UK Ltd
      • NuVasive, Inc.
      • Clinical Trial Overview of NuVasive, Inc.
      • AOSpine International
      • Clinical Trial Overview of AOSpine International
      • Acorda Therapeutics, Inc.
      • Clinical Trial Overview of Acorda Therapeutics, Inc.
    • Clinical Trial Overview of Top Institutes / Government
      • Simon Fraser University
      • Clinical Trial Overview of Simon Fraser University
      • Tehran University of Medical Sciences
      • Clinical Trial Overview of Tehran University of Medical Sciences
      • Shanghai Changzheng Hospital
      • Clinical Trial Overview of Shanghai Changzheng Hospital
      • Christian Medical College
      • Clinical Trial Overview of Christian Medical College
      • Indian Council of Medical Research
      • Clinical Trial Overview of Indian Council of Medical Research
      • Rennes University Hospital
      • Clinical Trial Overview of Rennes University Hospital
      • Yonsei University
      • Clinical Trial Overview of Yonsei University
      • Capital District Health Authority, Canada
      • Clinical Trial Overview of Capital District Health Authority, Canada
      • Hadassah Medical Organization
      • Clinical Trial Overview of Hadassah Medical Organization
      • University of Miami
      • Clinical Trial Overview of University of Miami
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Traumatic Spinal Cord Injury Therapeutics, Global, Clinical Trials by Region, 2014*
  • Traumatic Spinal Cord Injury Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Traumatic Spinal Cord Injury Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Traumatic Spinal Cord Injury Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014*
  • Traumatic Spinal Cord Injury Therapeutics Clinical Trials, Europe, Top Countries, 2014*
  • Traumatic Spinal Cord Injury Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Traumatic Spinal Cord Injury Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014*
  • Proportion of Traumatic Spinal Cord Injury to Central Nervous System Clinical Trials, G7 Countries (%), 2014*
  • Traumatic Spinal Cord Injury Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Traumatic Spinal Cord Injury Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Traumatic Spinal Cord Injury to Central Nervous System Clinical Trials, E7 Countries (%), 2014*
  • Traumatic Spinal Cord Injury Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Traumatic Spinal Cord Injury Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Traumatic Spinal Cord Injury Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Traumatic Spinal Cord Injury Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Traumatic Spinal Cord Injury Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Traumatic Spinal Cord Injury Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Traumatic Spinal Cord Injury Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Traumatic Spinal Cord Injury Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Traumatic Spinal Cord Injury Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Traumatic Spinal Cord Injury Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Traumatic Spinal Cord Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Stem Cell Sciences UK Ltd, 2014*
  • Traumatic Spinal Cord Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by NuVasive, Inc., 2014*
  • Traumatic Spinal Cord Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by AOSpine International, 2014*
  • Traumatic Spinal Cord Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Acorda Therapeutics, Inc., 2014*
  • Traumatic Spinal Cord Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Simon Fraser University, 2014*
  • Traumatic Spinal Cord Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Tehran University of Medical Sciences, 2014*
  • Traumatic Spinal Cord Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Shanghai Changzheng Hospital, 2014*
  • Traumatic Spinal Cord Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Christian Medical College, 2014*
  • Traumatic Spinal Cord Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Indian Council of Medical Research, 2014*
  • Traumatic Spinal Cord Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Rennes University Hospital, 2014*
  • Traumatic Spinal Cord Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Yonsei University, 2014*
  • Traumatic Spinal Cord Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Capital District Health Authority, Canada, 2014*
  • Traumatic Spinal Cord Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Hadassah Medical Organization, 2014*
  • Traumatic Spinal Cord Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Miami, 2014*

List of Figures

  • Traumatic Spinal Cord Injury Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Traumatic Spinal Cord Injury Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Traumatic Spinal Cord Injury Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Traumatic Spinal Cord Injury Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014*
  • Traumatic Spinal Cord Injury Therapeutics Clinical Trials, Europe, Top Countries (%), 2014*
  • Traumatic Spinal Cord Injury Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Traumatic Spinal Cord Injury Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014*
  • Proportion of Traumatic Spinal Cord Injury to Central Nervous System Clinical Trials, G7 Countries (%), 2014*
  • Traumatic Spinal Cord Injury Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Traumatic Spinal Cord Injury Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Traumatic Spinal Cord Injury to Central Nervous System Clinical Trials, E7 Countries (%), 2014*
  • Traumatic Spinal Cord Injury Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Traumatic Spinal Cord Injury Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Traumatic Spinal Cord Injury Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Traumatic Spinal Cord Injury Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Traumatic Spinal Cord Injury Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Traumatic Spinal Cord Injury Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Traumatic Spinal Cord Injury Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Traumatic Spinal Cord Injury Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Traumatic Spinal Cord Injury Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top